Ugur Ozbek Selected Research

Ugur Ozbek Research Topics

Disease

13	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 02/2007
7	Leukemia 01/2019 - 12/2002
5	Neoplasms (Cancer) 04/2015 - 03/2005
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2021 - 09/2005
3	COVID-19 11/2021 - 01/2021
3	Philadelphia Chromosome 12/2018 - 10/2016
3	Coronary Artery Disease (Coronary Atherosclerosis) 05/2013 - 01/2011
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2012 - 06/2005
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2021 - 01/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011 - 11/2008
2	Inflammation (Inflammations) 01/2007 - 09/2005
1	Smallpox (Variola) 01/2021
1	Hepatitis A (Hepatitis, Infectious) 01/2021
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2020
1	Autoimmune Diseases (Autoimmune Disease) 11/2020
1	Chronic Disease (Chronic Diseases) 11/2020
1	Ischemia 09/2020
1	Reperfusion Injury 09/2020
1	Hereditary Spastic Paraplegia 01/2019
1	Paraplegia (Spastic Paraplegia) 01/2019
1	Pantothenate Kinase-Associated Neurodegeneration (Hallervorden-Spatz Disease) 03/2017
1	Primary Myelofibrosis (Myelosclerosis) 09/2016
1	Pleural Effusion (Pleural Effusions) 07/2014
1	Lymphocytosis 07/2014
1	Reflex Epilepsy (Photosensitive Epilepsy) 10/2012
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2012
1	Penile Induration (Peyronie's Disease) 09/2012
1	Lung Diseases (Lung Disease) 07/2012
1	Genetic Translocation (Chromosomal Translocation) 03/2012
1	Lymphoma (Lymphomas) 01/2012
1	Schizophrenia (Dementia Praecox) 05/2010
1	Long QT Syndrome 05/2010
1	Cardiac Arrhythmias (Arrythmia) 04/2008
1	Carcinogenesis 01/2008
1	Pituitary Neoplasms (Pituitary Adenoma) 10/2007
1	Hyperplasia 08/2007
1	Appendicitis 01/2007

Drug/Important Bio-Agent (IBA)

7	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 02/2007
6	Proteins (Proteins, Gene)FDA Link 10/2021 - 09/2012
6	Tyrosine Kinase InhibitorsIBA 01/2019 - 09/2016
4	nilotinib FDA Link 12/2018 - 10/2016
3	Protein Isoforms (Isoforms)IBA 10/2021 - 01/2012
3	Phosphotransferases (Kinase)IBA 01/2019 - 09/2011
3	Dasatinib (BMS 354825)FDA Link 05/2018 - 09/2011
3	Ether (Diethyl Ether)IBA 04/2015 - 04/2008
3	EnzymesIBA 07/2012 - 03/2005
2	VaccinesIBA 11/2021 - 01/2021
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2020 - 08/2006
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 05/2013 - 09/2012
2	Messenger RNA (mRNA)IBA 11/2008 - 01/2007
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 03/2006 - 03/2005
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 03/2006 - 03/2005
2	Biological ProductsIBA 09/2005 - 12/2002
1	Inosine Triphosphate (ITP)IBA 11/2020
1	HydrogenIBA 09/2020
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 09/2020
1	IronIBA 01/2019
1	bosutinibIBA 05/2018
1	ponatinibIBA 05/2018
1	pantothenate kinaseIBA 03/2017
1	Reticulin (Reticular Fiber)IBA 09/2016
1	ReninIBA 12/2013
1	11-beta-Hydroxysteroid Dehydrogenases (11beta Hydroxysteroid Dehydrogenase)IBA 05/2013
1	Hydroxysteroid DehydrogenasesIBA 05/2013
1	Carrier Proteins (Binding Protein)IBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2013
1	Tyrosine (L-Tyrosine)FDA Link 01/2013
1	ZincIBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 01/2013
1	11-beta-Hydroxysteroid Dehydrogenase Type 1IBA 09/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2012
1	GlucocorticoidsIBA 09/2012
1	Fas Ligand Protein (Fas Ligand)IBA 09/2012
1	Caspase 3 (Caspase-3)IBA 09/2012
1	Glutathione Transferase (Glutathione S-Transferase)IBA 07/2012
1	PhosphoproteinsIBA 03/2012
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2012
1	LeptinIBA 01/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2011
1	AdiponectinIBA 01/2011
1	Potassium Channels (Potassium Channel)IBA 05/2010
1	Intergenic DNA (Junk DNA)IBA 05/2010
1	Antipsychotic Agents (Antipsychotics)IBA 05/2010
1	Interferon-alpha (Interferon Alfa)IBA 10/2009
1	Fatty Acid-Binding ProteinsIBA 11/2008
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2008
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2008
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2008
1	Cyclin D1IBA 10/2007
1	beta CateninIBA 08/2007
1	Nuclear Pore Complex Proteins (Nucleoporins)IBA 08/2007
1	PyrinIBA 01/2007

Therapy/Procedure

4	Therapeutics 01/2019 - 11/2008
1	Ligation 01/2019
1	Hematopoietic Stem Cell Transplantation 05/2018
1	Salvage Therapy 05/2018
1	Stem Cell Transplantation 02/2007
1	Drug Therapy (Chemotherapy) 02/2007
1	Preoperative Period 01/2007